1-4 of 4
Hongwei Yin, PHD
Close
Sort by
Journal Articles

Pharmacological Validation Of Potentiating Targets From SAHA RNA-Interference Modifier Screens In Acute Myeloid Leukemia

James M Bogenberger, PhD, James Rudd, Donald Chow, Michelle Kassner, Veena Fauble, MD, Ruben A. Mesa, MD, Hongwei Yin, PHD, Casey Greene, PhD, Raoul Tibes, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3832.
https://doi.org/10.1182/blood.V122.21.3832.3832
Published: 2013
Journal Articles

RNAi Screening of the Human Kinome Identifies Inhibition of WEE1 Kinase As Potent and Universal Sensitizing Target to Cytarabine in Leukemias

Raoul Tibes, MD, PhD, Leena Chaudhuri, PhD, James M Bogenberger, PhD, Tanner R Hagelstrom, PhD, MBA, Amanda McNally, MS, Donald Chow, Megan E Buechel, MS, Irma Gonzales, Esteban Braggio, PhD, Hongwei Yin, PHD, Shilpi Arora, PhD, David Azorsa, PhD, Craig B. Reeder, MD, Pierre Noel, MD, James L. Slack, MD, Ruben A. Mesa, MD, Tim Demuth, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 229.
https://doi.org/10.1182/blood.V118.21.229.229
Published: 2011
Journal Articles

Kinome-Wide RNAi Studies in Human Multiple Myeloma Identify a Lymphoid Restricted Kinase GRK6 as a Selectively Vulnerable Target That Regulates STAT3/MCL1.

Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Yuan Xiao Zhu, Jessica Schmidt, BS, Hongwei Yin, PhD, Quick Que, PhD, David Azorsa, PhD, Louise M. Perkins, PhD, Esteban Braggio, PhD, Craig B. Reeder, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Spyro Mousses, PhD, A. Keith Stewart, MD
Journal: Blood
Blood (2009) 114 (22): 601.
https://doi.org/10.1182/blood.V114.22.601.601
Published: 2009
Journal Articles

Achilles Heel Molecular Vulnerabilities in Multiple Myeloma Identified From Genome-Scale RNA Interference Screening.

Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Yuan Xiao Zhu, Jessica Schmidt, BS, Chang-Xin Shi, Hongwei Yin, PhD, Spyro Mousses, PhD, A. Keith Stewart, MD
Journal: Blood
Blood (2009) 114 (22): 2801.
https://doi.org/10.1182/blood.V114.22.2801.2801
Published: 2009